Profile picture

Mr Gijs Berkelmans

University Medical Center Utrecht, Utrecht (Netherlands (The))
Follow
Logo ESC

Contributor content

Treatment decisions based on individual estimated lifetime benefit versus individual estimated 10-year absolute risk reduction: a cost-effectiveness analyses with PCSK9 inhibition.
Presentation
Treatment decisions based on individual estimated lifetime benefit versus individual estimated 10-year absolute risk reduction: a cost-effectiveness analyses with PCSK9 inhibition.
Read more
Dealing with missing patient characteristics in clinical practice when using cardiovascular prediction models.
Presentation
Dealing with missing patient characteristics in clinical practice when using cardiovascular prediction models.
Read more
Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.
Presentation
Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.
Read more

ESC 365 is supported by

novartis Explore sponsored resources